Advertisement

Obg Management Logo Home
   
   
Free CME
Classifieds
Register/Login
Home Page Current Issue Past Issues Supplements Podcasts Information for Authors
                                    
   
About Us
Subscribe Renew
Reprints Permissions
Advertising Information
Links and Resources
Classifieds

Advertisement

December 2010 · Vol. 22, No. 12

FOURTH OF FOUR PARTS

Skilled US imaging of the adnexae
Part 4: The fallopian tubes

The tubes shed some of their mystery during interrogation by ultrasonography, which can highlight abnormalities such as inflammation, infection, torsion, and cancer


Dr. Timor-Tritsch sums up this series on imaging

READ THE WHOLE SERIES

Part 1 A Starting Point (September 2010)

Part 2 The non-neoplastic ovarian mass (October 2010)

Part 3 Ovarian neoplasms (November 2010)

IN THIS ARTICLE

Ilan  E.  Timor-Tritsch,  MD

Dr. Timor-Tritsch is Professor of ObGyn and Director of ObGyn Ultrasound at New York University Medical Center in New York City.

Steven  R.  Goldstein,  MD

Dr. Goldstein is Professor of ObGyn, Director of Gynecologic Ultrasound, and Co-Director of Bone Densitometry at New York University Medical Center in New York City. He serves on the OBG Management Board of Editors.

Dr. Timor-Tritsch reports no financial relationships relevant to this article. Dr. Goldstein reports that he is an advisor to Amgen, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Merck, and Pfizer. He also serves as a consultant to Cook ObGyn and Philips Ultrasound and as a speaker for Eli Lilly and Warner Chilcott. He is a director of Sonosite, Inc.

An imaging study of the adnexae would not be complete without thorough assessment of the fallopian tubes. Among the pathologies that may be identified or confirmed by ultrasonography are:

Sign in now to read more...

Back to top


Advertisement



Advertisement1


XMLRSS callout
 

Advertisement